These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
248 related articles for article (PubMed ID: 27230284)
1. Butyrate upregulates endogenous host defense peptides to enhance disease resistance in piglets via histone deacetylase inhibition. Xiong H; Guo B; Gan Z; Song D; Lu Z; Yi H; Wu Y; Wang Y; Du H Sci Rep; 2016 May; 6():27070. PubMed ID: 27230284 [TBL] [Abstract][Full Text] [Related]
5. Relative nephroprotection during Escherichia coli O157:H7 infections: association with intravenous volume expansion. Ake JA; Jelacic S; Ciol MA; Watkins SL; Murray KF; Christie DL; Klein EJ; Tarr PI Pediatrics; 2005 Jun; 115(6):e673-80. PubMed ID: 15930195 [TBL] [Abstract][Full Text] [Related]
6. Soluble Fas and soluble Fas-ligand in children with Escherichia coli O157:H7-associated hemolytic uremic syndrome. Masri C; Proulx F; Toledano B; Clermont MJ; Mariscalco MM; Seidman EG; Carcillo J Am J Kidney Dis; 2000 Oct; 36(4):687-94. PubMed ID: 11007669 [TBL] [Abstract][Full Text] [Related]
7. Immunogenicity of recombinant porcine attaching and effacing-associated protein compared with intimin fragment in Escherichia coli O157:H7-infected mice. Li T; Han R; Wang Q; Wang S; Fang H; Li Z; Tu W; Wang D; Wang H Foodborne Pathog Dis; 2013 Dec; 10(12):1016-22. PubMed ID: 24093308 [TBL] [Abstract][Full Text] [Related]
8. Caprylic acid and nonanoic acid upregulate endogenous host defense peptides to enhance intestinal epithelial immunological barrier function via histone deacetylase inhibition. Wang J; Huang N; Xiong J; Wei H; Jiang S; Peng J Int Immunopharmacol; 2018 Dec; 65():303-311. PubMed ID: 30342347 [TBL] [Abstract][Full Text] [Related]
9. Increased serum IL-10 and endothelin levels in hemolytic uremic syndrome caused by Escherichia coli O157. Yamamoto T; Nagayama K; Satomura K; Honda T; Okada S Nephron; 2000 Apr; 84(4):326-32. PubMed ID: 10754409 [TBL] [Abstract][Full Text] [Related]
11. Dysregulation of angiopoietin 1 and 2 in Escherichia coli O157:H7 infection and the hemolytic-uremic syndrome. Page AV; Tarr PI; Watkins SL; Rajwans N; Petruzziello-Pellegrini TN; Marsden PA; Kain KC; Liles WC J Infect Dis; 2013 Sep; 208(6):929-33. PubMed ID: 23801605 [TBL] [Abstract][Full Text] [Related]
12. Effect of early oral fluoroquinolones in hemorrhagic colitis due to Escherichia coli O157:H7. Shiomi M; Togawa M; Fujita K; Murata R Pediatr Int; 1999 Apr; 41(2):228-32. PubMed ID: 10221035 [TBL] [Abstract][Full Text] [Related]
13. Isotype-specific antibody responses against Escherichia coli O157:H7 locus of enterocyte effacement proteins in adult beef cattle following experimental infection. Bretschneider G; Berberov EM; Moxley RA Vet Immunol Immunopathol; 2007 Aug; 118(3-4):229-38. PubMed ID: 17617472 [TBL] [Abstract][Full Text] [Related]
14. Saliva IgM and IgA are a sensitive indicator of the humoral immune response to Escherichia coli O157 lipopolysaccharide in children with enteropathic hemolytic uremic syndrome. Ludwig K; Grabhorn E; Bitzan M; Bobrowski C; Kemper MJ; Sobottka I; Laufs R; Karch H; Müller-Wiefel DE Pediatr Res; 2002 Aug; 52(2):307-13. PubMed ID: 12149511 [TBL] [Abstract][Full Text] [Related]
15. Intranasal immunization with novel EspA-Tir-M fusion protein induces protective immunity against enterohemorrhagic Escherichia coli O157:H7 challenge in mice. Lin R; Zhu B; Zhang Y; Bai Y; Zhi F; Long B; Li Y; Wu Y; Wu X; Fan H Microb Pathog; 2017 Apr; 105():19-24. PubMed ID: 28163157 [TBL] [Abstract][Full Text] [Related]
16. A systemic vaccine based on Escherichia coli O157:H7 bacterial ghosts (BGs) reduces the excretion of E. coli O157:H7 in calves. Vilte DA; Larzábal M; Mayr UB; Garbaccio S; Gammella M; Rabinovitz BC; Delgado F; Meikle V; Cantet RJ; Lubitz P; Lubitz W; Cataldi A; Mercado EC Vet Immunol Immunopathol; 2012 Apr; 146(2):169-76. PubMed ID: 22460171 [TBL] [Abstract][Full Text] [Related]
17. Mannan-binding lectin in children with Escherichia coli O157:H7 haemmorrhagic colitis and haemolytic uraemic syndrome. Proulx F; Wagner E; Toledano B; Decaluwe H; Seidman EG; Rivard GE Clin Exp Immunol; 2003 Sep; 133(3):360-3. PubMed ID: 12930361 [TBL] [Abstract][Full Text] [Related]
18. From In silico Protein Epitope Density Prediction to Testing Escherichia coli O157:H7 Vaccine Candidates in a Murine Model of Colonization. Tapia D; Ross BN; Kalita A; Kalita M; Hatcher CL; Muruato LA; Torres AG Front Cell Infect Microbiol; 2016; 6():94. PubMed ID: 27625996 [TBL] [Abstract][Full Text] [Related]
19. The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections. Wong CS; Jelacic S; Habeeb RL; Watkins SL; Tarr PI N Engl J Med; 2000 Jun; 342(26):1930-6. PubMed ID: 10874060 [TBL] [Abstract][Full Text] [Related]
20. Differences in virulence among Escherichia coli O157:H7 strains isolated from humans during disease outbreaks and from healthy cattle. Baker DR; Moxley RA; Steele MB; Lejeune JT; Christopher-Hennings J; Chen DG; Hardwidge PR; Francis DH Appl Environ Microbiol; 2007 Nov; 73(22):7338-46. PubMed ID: 17890332 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]